Wikisage, the free encyclopedia of the second generation, is digital heritage

Rufinamide: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 5: Line 5:
<small>"Rufinamide received the status of orphan drug for [[epilepsy]] in 2004 in Europe"</small>
<small>"Rufinamide received the status of orphan drug for [[epilepsy]] in 2004 in Europe"</small>
<ref>[http://onlinelibrary.wiley.com/doi/10.1111/epi.12689/epdf  Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience]</ref>
<ref>[http://onlinelibrary.wiley.com/doi/10.1111/epi.12689/epdf  Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience]</ref>
<gallery>File:Rufinamid.svg.png</gallery>


It is an inductor of [[Cytochrome P450|CYP 450]]
It is an inductor of [[Cytochrome P450|CYP 450]]
Line 14: Line 13:
[http://www.pharmawiki.ch/wiki/index.php?wiki=Rufinamid Pharmawiki:Rufinamid]
[http://www.pharmawiki.ch/wiki/index.php?wiki=Rufinamid Pharmawiki:Rufinamid]
==[[ATC]]==
==[[ATC]]==
<gallery>File:Rufinamid.svg.png</gallery>
https://www.whocc.no/atc_ddd_index/?code=N03AF03
https://www.whocc.no/atc_ddd_index/?code=N03AF03


<references/>
{{refs}}


{{Wikidata|Q408565}}
{{Wikidata|Q408565}}


[[Category:Anticonvulsants]]
[[Category:Anticonvulsants]]

Latest revision as of 20:41, 20 March 2023

Lennox-Gastaut is a low prevalence epileptic syndrome (1:10000), and Cochrane Epilepsy Group concluded that treatment remain unconclusive. Otsuka et al. (2014) state rufinamide as an efficacious and well tolerated AED [1](cf. Alssad et Coren 2014) [2]

"Rufinamide received the status of orphan drug for epilepsy in 2004 in Europe" [3]

It is an inductor of CYP 450

Weblinks

FLexikon:Rufinamid

Pharmawiki:Rufinamid

ATC

https://www.whocc.no/atc_ddd_index/?code=N03AF03

References

References:

Q408565 at Wikidata  Interwiki via Wikidata